So-Young International Inc (SY)
0.8801
+0.08
(+10.05%)
USD |
NASDAQ |
Nov 14, 16:00
0.8801
0.00 (0.00%)
After-Hours: 20:00
So-Young International Enterprise Value: -56.40M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | -56.40M |
| November 12, 2024 | -65.45M |
| November 11, 2024 | -51.16M |
| November 08, 2024 | -49.72M |
| November 07, 2024 | -45.15M |
| November 06, 2024 | -51.24M |
| November 05, 2024 | -46.77M |
| November 04, 2024 | -48.97M |
| November 01, 2024 | -50.14M |
| October 31, 2024 | -46.66M |
| October 30, 2024 | -43.62M |
| October 29, 2024 | -40.05M |
| October 28, 2024 | -38.01M |
| October 25, 2024 | -35.46M |
| October 24, 2024 | -30.87M |
| October 23, 2024 | -36.48M |
| October 22, 2024 | -35.97M |
| October 21, 2024 | -35.46M |
| October 18, 2024 | -34.44M |
| October 17, 2024 | -37.29M |
| October 16, 2024 | -36.99M |
| October 15, 2024 | -33.48M |
| October 14, 2024 | -26.79M |
| October 11, 2024 | -27.81M |
| October 10, 2024 | -31.89M |
| Date | Value |
|---|---|
| October 09, 2024 | -29.85M |
| October 08, 2024 | -24.75M |
| October 07, 2024 | -20.66M |
| October 04, 2024 | -14.55M |
| October 03, 2024 | -16.07M |
| October 02, 2024 | -13.52M |
| October 01, 2024 | -33.93M |
| September 30, 2024 | -42.09M |
| September 27, 2024 | -46.22M |
| September 26, 2024 | -53.31M |
| September 25, 2024 | -63.89M |
| September 24, 2024 | -61.40M |
| September 23, 2024 | -62.69M |
| September 20, 2024 | -63.00M |
| September 19, 2024 | -62.90M |
| September 18, 2024 | -57.51M |
| September 17, 2024 | -53.41M |
| September 16, 2024 | -56.37M |
| September 13, 2024 | -52.30M |
| September 12, 2024 | -58.41M |
| September 11, 2024 | -53.86M |
| September 10, 2024 | -55.86M |
| September 09, 2024 | -58.41M |
| September 06, 2024 | -54.84M |
| September 05, 2024 | -53.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-163.76M
Minimum
Oct 31 2022
1.324B
Maximum
Feb 19 2021
266.58M
Average
18.25M
Median
Enterprise Value Benchmarks
| Sinovac Biotech Ltd | -6.942B |
| CASI Pharmaceuticals Inc | 91.55M |
| Zai Lab Ltd | 2.423B |
| Adagene Inc | 29.78M |
| LakeShore Biopharma Co Ltd | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.633M |
| Revenue (Quarterly) | 56.64M |
| Total Expenses (Quarterly) | 55.70M |
| EPS Diluted (Quarterly) | 0.0257 |
| Gross Profit Margin (Quarterly) | 61.94% |
| Profit Margin (Quarterly) | 4.65% |
| Earnings Yield | 5.31% |
| Normalized Earnings Yield | 4.662 |